MicroPort CardioFlow Medtech Corporation (Stock Code: 2160) concluded an Extraordinary General Meeting on February 11, 2026, where shareholders passed a resolution by poll to approve a share consolidation. According to the company’s announcement, the resolution received 4,038,107,450 votes in favor, with no votes against. The existing total of 6,366,557,195 issued shares were eligible to vote on the resolution.

The share consolidation will take effect on February 24, 2026, leading to 1,273,311,439 consolidated shares in issue and fully paid. Dealings in the new consolidated shares will begin at 9:00 a.m. on the same day. Certificates for the consolidated shares will be issued in light gold, while the existing blue certificates will remain valid only as title documents.

Outstanding share options will be adjusted in terms of exercise price and the number of consolidated shares to be issued upon exercise. The announcement notes that the independent auditor, KPMG, confirmed calculations related to these adjustments, which were made in accordance with the relevant listing rules and the terms of the company’s share schemes.